Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug

/PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....

Related Keywords

Israel ,Laine Yonker ,Ruth Perets ,Rivka Neufeld ,Joseph Green ,Elran Haber ,Sloan Kettering ,Lavie Bio Ltd ,Biomica Ltd ,Evogene Ltd ,Israel Ministry Of Health ,Nasdaq ,Edison Group ,Research Centers ,Rambam Health ,Casterra Ag Ltd ,Canonic Ltd ,John Hopkins Medical Center ,Israeli Ministry Of Health Mo ,Agplenus Ltd ,Rambam Health Care Campus ,Israel Institute Of Technology ,Stanford University ,Israeli Ministry ,Care Campus ,Oncology Phase ,Objective Response Rate ,Percent Tumor Growth Inhibition ,Live Bacterial Product ,Computational Predictive Biology ,Health Care Campus ,Rambam Medical ,Big Data ,Technion Israel Institute ,Beth Israel Harvard Deaconess Hospital ,Artificial Intelligence ,Public Relations ,Thorac Oncol ,Rambam Health Care ,Biomica Ltd Rambam Health Care Campus ,